This is the authors' abstract. We don't add key points for this paper.
A previously healthy 18-year-old man with a 9-month history of upper abdominal pain and significant weight loss underwent gastroscopy, revealing an ulcerative lesion in the duodenal bulb. Enrolled in a clinical trial, both 18 F-FDG and 68 Ga-FAPI-04 PET/CT demonstrated similar metabolic activity, though 68 Ga-FAPI-04 offered superior lesion delineation. Pathology confirmed synovial sarcoma. This case highlights the potential utility of 68 Ga-FAPI-04 as a radiopharmaceutical for evaluating rare gastrointestinal synovial sarcomas.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: